2020 Joint AAPM | COMP Virtual Meeting
Back to session list

Session Title: The Radiation Oncology Data Sharing Landscape: Registries, Clinical Trials, Data Warehouses
Question 1: When working to align entries in your record and verify system to streamline data collection for use in the cancer registry, which of the following may be useful resources:
Reference:Commission on Cancer, Standards for Oncology Registry Entry STORE, Released 2018, American College of Surgeons Available at https://www.facs.org/~/media/files/quality%20programs/cancer/ncdb/store_manual_2018.ashx
Choice A:A conversation with your hospital or state cancer registrar(s)
Choice B:TG263 Standardizing Nomenclatures in Radiation Oncology
Choice C:Standards for Oncology Registry Entry (STORE) 2018
Choice D:a. and c.
Question 2: Which section of the Commission on Cancer (CoC) consensus standardized radiation treatment summary would one use to determine the cumulative dose to the prostate in course of radiation treatment?
Reference:John P. Christodouleas, Nathan Anderson, Peter Gabriel, Rick Greene, Carol Hahn, Susanne Kessler, Charles S. Mayo, Todd McNutt, Lawrence N. Shulman, Benjamin D. Smith, Jeff West, Ted Williamson, A Multidisciplinary Consensus Recommendation on a Synoptic Radiation Treatment Summary: A Commission on Cancer Workgroup Report, Practical Radiation Oncology, 2020, In Press, Accessed May 21, 2020, ISSN 1879-8500 https://doi.org/10.1016/j.prro.2020.01.002.
Choice A:Radiation course summary
Choice B:Anatomic target summary
Choice C:Delivered prescription summary
Choice D:This information is not in the standardized radiation treatment summary
Question 3: You are initiating a new clinical trial, what are the steps to encourage sharing and secondary use of data?
Reference:Reference: Taichman, D., Backus, J., Baethge, C., et al. Sharing Clinical Trial Data — A Proposal from the International Committee of Medical Journal Editors. N Engl J Med 374, 384-386 (2016)
Choice A:Secondary use will handled at the time by the researchers who wish to use the data.
Choice B:Data sharing is routinely open without additional requirements
Choice C:Data sharing plan as part of a clinical trial’s registration
Question 4: What are the steps in a formal, controlled clinical trial data sharing request?
Reference:Reference: Tudur Smith, C., Hopkins, C., Sydes, M.R. et al. How should individual participant data (IPD) from publicly funded clinical trials be shared?. BMC Med 13, 298 (2015).
Choice A:Contact the authors of the initial publication and request direct access
Choice B:Complete access request, request specific data elements, include research proposal, prepare and sign data use agreement, receive data
Choice C:Complete access request, request all data, prepare and sign data use agreement, receive data
Choice D:Contact the authors, send research proposal, request all data, receive data
Question 5: Where can AAPM members find information on which vendors have adhere to IHE RO profiles?
Reference:https://www.aapm.org/IHERO/default.asp
Choice A:Your vendor sales representative.
Choice B:AAPM IHE RO Website.
Choice C:The FDA website
Choice D:A and B
Question 6: The Basic Radiotherapy Objects (BRTO II) profile specifies how to send …
Reference:http://www.ihe-ro.org/doku.php?id=doc:profiles
Choice A:CT, Structures, Dose
Choice B:DICOM Plans and Machine Configuration
Choice C:Treatment History to EMRs
Choice D:MLC Control Points
Back to session list